Literature DB >> 11159140

Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation.

E Faerstein1, M Szklo, N B Rosenshein.   

Abstract

In this case-control study, the authors analyzed associations of uterine leiomyoma with atherogenic risk factors and potential sources of uterine irritation. The study included 318 case women with uterine leiomyoma that was first confirmed between 1990 and 1993 in the Baltimore, Maryland, area and 394 controls selected from women visiting the same gynecologists' offices for routine reasons. Telephone interviews were conducted with 77.8% of eligible cases and 78.0% of eligible controls. Compared with participants with no hypertension history, increased risks were observed among participants with any history of hypertension (odds ratio (OR) = 1.7; 95% confidence interval (CI): 1.0, 2.8), hypertension requiring medication (OR = 2.1; 95% CI: 1.1, 4.1), hypertension diagnosed at ages less than 35 years (for hypertension requiring medication, OR = 2.7; 95% CI: 1.0, 7.6), and hypertension of 5 or more years' duration (for hypertension requiring medication, OR = 3.1; 95% CI: 1.2, 8.2). Estimates of associations with diabetes history were very imprecise but followed similar patterns. Adjusted associations were observed with pelvic inflammatory disease (three or more episodes vs. none: OR = 3.7; 95% CI: 0.9, 15.9), chlamydial infection (history vs. no history: OR = 3.2; 95% CI: 0.8, 13.7), and use of an intrauterine device when it caused infectious complications (use vs. no use: OR = 5.3; 95% CI: 1.8, 16.3). Risk of uterine leiomyoma was also associated in a graded fashion with frequency of perineal talc use (daily use vs. no use: OR = 2.2; 95% CI: 1.4, 3.1). The authors conclude that nonhormonal factors may influence risk of uterine leiomyoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159140     DOI: 10.1093/aje/153.1.11

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  59 in total

1.  Chlamydia trachomatis Seroprevalence and Ultrasound-Diagnosed Uterine Fibroids in a Large Population of Young African-American Women.

Authors:  Kristen R Moore; Jennifer S Smith; Stephen R Cole; Dirk P Dittmer; Victor J Schoenbach; Donna D Baird
Journal:  Am J Epidemiol       Date:  2018-02-01       Impact factor: 4.897

2.  Self-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women.

Authors:  Kristen R Moore; Stephen R Cole; Dirk P Dittmer; Victor J Schoenbach; Jennifer S Smith; Donna D Baird
Journal:  J Womens Health (Larchmt)       Date:  2015-04-22       Impact factor: 2.681

3.  Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation.

Authors:  Shannon K Laughlin-Tommaso; Zaraq Khan; Amy L Weaver; Cathy D Schleck; Walter A Rocca; Elizabeth A Stewart
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

4.  Uterine leiomyomata in a cohort of Great Lakes sport fish consumers.

Authors:  Anissa Lambertino; Mary Turyk; Henry Anderson; Sally Freels; Victoria Persky
Journal:  Environ Res       Date:  2011-02-09       Impact factor: 6.498

5.  Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility.

Authors:  Hao Huang; Hongying Kuang; Fangbai Sun; Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter R Casson; Gregory M Christman; Karl R Hansen; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  Fertil Steril       Date:  2019-03-27       Impact factor: 7.329

6.  BET1L and TNRC6B associate with uterine fibroid risk among European Americans.

Authors:  Todd L Edwards; Kara A Michels; Katherine E Hartmann; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2013-04-19       Impact factor: 4.132

7.  Hypertension and risk of uterine leiomyomata in US black women.

Authors:  R G Radin; L Rosenberg; J R Palmer; Y C Cozier; S K Kumanyika; L A Wise
Journal:  Hum Reprod       Date:  2012-02-26       Impact factor: 6.918

8.  Enhancing uterine fibroid research through utilization of biorepositories linked to electronic medical record data.

Authors:  Lani Feingold-Link; Todd L Edwards; Sarah Jones; Katherine E Hartmann; Digna R Velez Edwards
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

9.  Lipopolysaccharide activated TLR4/NF-κB signaling pathway of fibroblasts from uterine fibroids.

Authors:  Jing Guo; Lihua Zheng; Li Chen; Ning Luo; Weihong Yang; Xiaoyan Qu; Mingmin Liu; Zhongping Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 10.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.